전체 논문 (41편 · 1/2)
-
Exploration of a prognostic model for childhood acute lymphoblastic leukemia.
-
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors.
-
In silico identification of deleterious NT5C2 and PRPS1 mutations driving thiopurine resistance in relapsed acute lymphoblastic leukemia.
-
Persistent monosomy 7 in Philadelphia chromosome-negative cells without disease progression over nearly two decades of follow-up in chronic myeloid leukemia.
-
Genetic polymorphisms of tumor necrosis factor receptor-associated factor 3 and their association with acute lymphoblastic leukemia.
-
DNMT3A R882C variant in a patient with a presumed pineal gland tumor, highlighting potential tumor susceptibility in Tatton-Brown-Rahman syndrome.
-
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases.
-
Altered expression of nucleotide excision repair genes ERCC2 and ERCC5 in prostate cancer tissues.
-
Investigation of hnRNPK's role in gastric cancer proliferation and migration and its interaction with TL1A.
-
Autophagy inhibition enhances PD-1 blockade efficacy in mismatch repair-proficient colorectal cancer.
-
Germline APC I1307K and MITF E318K variants in a patient with high-grade serous ovarian carcinoma: A case report.
-
Context-specific roles of DDX60 in colorectal cancer via autophagy regulation and DDX58 signaling.
-
A novel in vitro colorectal cancer model for investigating ABCB1- and ABCC1-mediated multidrug resistance.
-
Germline lung cancer SNPs dysregulate known (LATS1) and novel (ADCY2) oncogenes through distal, spatially-constrained eQTLs.
-
Genetic modulation of ABCB1: Sunvozertinib reverses ABCB1-mediated multidrug resistance in cancer cells.
-
Driver gene mutations and clinical features predict bone metastasis risk in NSCLC: a logistic regression model.
-
Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patients.
-
Comparative analysis of a founder BRCA2 double mutation versus single mutation carriers reveals no additional clinical risk.
-
Quantitative and qualitative methods for measuring chromosomal instability in tumor cells.
-
Association of high and moderate penetrance monogenic variants, polygenic risk, and family history with breast cancer in an ancestrally diverse population.
-
Plasma cell-free DNA biomarkers as novel diagnostic and prognostic tools in breast cancer.
-
Transcription factor FOXP2 attenuates the stemness of breast cancer cells by abolishing the transcription of Twist1.
-
Specific variations in cfDNA methylation level of CDH1 and Gjb1 in a mouse model with breast cancer before and after metastasis.
-
M6A methylation in thyroid cancer: Functions, mechanisms, and clinical significance.
-
The role and prospects of the Fudan classification in precision medicine for triple-negative breast cancer.
-
Familial colorectal cancer: risk factors, screening strategies and personalized medicine.
-
SATB2 plays a critical role in pancreatic cancer cell proliferation, migration and T cell cytotoxicity.
-
Efficacy of pembrolizumab in MSI-high and BRCA-positive castration-resistant prostate cancer.
-
Upregulation of Uracil DNA Glycosylase (UNG) in Prostate Cancer.
-
The role of miR-10b-5p in prostate cancer and its exosome-mediated angiogenesis effect.